Vitasora Health Limited has released a press release.
Respiri Announces $4.3M Fully Underwritten Rights Issue
Filed with ASX ·
6ix hasn’t read this filing yet.
Vitasora Health Limited on 6ix
Earlier from Vitasora Health
- iSonea Strengthens Leadership in Respiratory mHealth Tech
- Respiri - Market Update (Feb 2016)
- Respiri Appendix 4D and Interim Financial Report - Dec 2015
- Appendix 4C - Second Quarter Cash Report - FY2016
- Appendix 4E - Preliminary Final Report - June 2015
Later from Vitasora Health
- Offer Booklet for Renounceable Pro-Rata Rights Issue
- Respiri $4.3M Rights Issue Closes With Success
- Independent Study Confirms AirSonea Detects Asthma Wheezing
- Appendix 4C - Fourth Quarter Cash Report - FY2016
- Appendix 4E & Annual Financial Report (30 June 2016)
Follow Vitasora Health into a list and get an email when it puts out news.
Follow Vitasora Health